Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity
Stefan Preković(University Medical Center Utrecht), Wilbert Zwart(Oncode Institute)
Cited by 26
Related Papers
Androgen receptor profiling predicts prostate cancer outcome
|EMBO Molecular Medicine|2015|92
Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence
|Cancer Discovery|2022|85
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer
|Nature Communications|2021|79
Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants of estrogen receptor α
|Molecular Cancer Therapeutics|2007|26